Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07308678) titled 'AQUACEL(R) Ag+ Extra™ vs Cutimed(R) Sorbact(R): A Blinded Re-Assessment of Randomized Controlled Trial Findings' on Dec. 17, 2025.
Study Type: Observational
Primary Sponsor: ConvaTec Inc.
Condition:
Venous Leg Ulcer
Diabetic Foot
Recruitment Status: Not recruiting
Date of First Enrollment: April 22, 2025
Target Sample Size: 105
Countries of Recruitment:
Germany
To know more, visit https://clinicaltrials.gov/study/NCT07308678
Published by HT Digital Content Services with permission from Health Daily Digest....